March 13, 2017 / 3:14 PM / 4 months ago

BRIEF-Sino Biopharmaceutical FY profit attributable HK$1.91 bln

1 Min Read

March 13 (Reuters) - Sino Biopharmaceutical Ltd:

* FY profit attributable to equity holders HK$1.91 billion, 7.6% higher

* FY revenue HK$ 15.83 billion versus HK$14.55 billion

* Company recommended payment of a final dividend of HK1.5 cents per share for year ended 31 December, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below